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fn the last 25 years, the world has become smaller
for the cardiovascular physician in the sense that
scientists and medical specialists have been able
o communicate in a manner that was previously un-
nown. There are 2 key reasons. The first is the air-
lane, which has allowed physicians from all over the
orld to travel to clinical and scientific meetings, to
ix more frequently with colleagues from many
ountries, and thus to establish new friendships and
ollaborations. The second, more recent reason, is the
evelopment of the Internet. A consequence is that
hysicians, patients, health workers, and politicians
ave access to an immense, and hitherto unthinkable,
ange of knowledge. All can exchange opinions more
uickly than ever before. Indeed, there is now such a
urfeit of Internet sites providing so-called news in
ardiology that one surmises there is a need to create
ews.
. .the world has become smaller for the cardiovascular
hysician. . .
A key difference between the medical profession
nd others, such as law or accountancy, is that the
nderlying reason for the existence of the medical
rofession is the prevention and treatment of disease,
hich is common to all humankind. It might be
rgued that crime also is common to all societies.
o it is, but whereas there are key difference in the
egal systems of countries, there is no reason for there
o be any fundamental difference in the treatment of
n identical disease in different countries. Cultures
ay determine different approaches to disease, buthe fundamental treatment of, say, pneumococcal ceningitis is universal. Medicine has become a
lobal specialty without borders.
The expectation would be that all treatments for
ll diseases would become similar in all countries, a
orm of regression to the mean. Experience shows that
s not so. Much might be learned from examining
hese differences and, for that reason, a series of arti-
les will appear in the Journal identifying attitudes
nd differences relating to medical practice in Europe
nd the world. Some continents have a perceived
dvantage over Europe, which has poorly defined
orders, and even those have varied in the course of
istory. Asia contains large countries, such as India
nd China, with central governments. The U.S. com-
rises 50 clearly defined states with a single constitu-
ion. Europe and the U.S. have strong historical links
ver since tobacco was offered to Christopher Colum-
us and the potato was brought to Europe by the
panish, possibly from Peru, and to my own country,
he United Kingdom, from Spanish Galleons or by
ir Francis Drake or Sir Walter Raleigh. The precise
istory is uncertain.
Nevertheless, there are considerable similarities
ith the health problems that are now being faced by
oth the continents of the world and Europe. These
nclude structures for the delivery of health services,
he financing of health services, the financing of medi-
al research, the perception of the benefit to accrue
. .there are considerable similarities with the health
roblems that are now being faced by both the conti-
ents of the world and Europe.
rom medical research, the development of careers for
linicians, clinical scientists and scientists and, finally,
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ften are reflected in what appear superficially to be small
lterations within existing organizations. For example, the
ritish Cardiac Society this year changed its name to the
ritish Cardiovascular Society. Cardiology is seen by some
o be a limiting word rather highjacked by the interven-
ional cardiologist and not portraying adequately a compre-
ensive approach to the people or patients who are a risk of
ardiovascular disease.
At the same time, there are more complex problems.
rofessionalism in the medical world is being challenged,
uthority is no longer accepted, the concept of the expert is
efuted, and public trust is diminished. The provision of
edical care and the actions of doctors may be at the whim
f nonmedically qualified managers; good management is
ot to be disparaged but management in excess separated
rom medical knowledge, often is to the disadvantage of the
atient.
One reason for current difficulties is success. During the
ast century, a shift has occurred in the causes of mortality
rom infection diseases to chronic diseases. The mean life
xpectancy has increased from approximately from 45 years
o 80 years. There is now a similarity in the life expectancy
f the richer countries of the world (Fig. 1). In almost all
ountries, substantial increases have occurred in the last few
ecades. Healthy life-years also have increased despite ac-
Figure 1 Life Expectancy at Birth in Countries
of the World, Year 2002 or 2004
Source: World Health Statistics 2006, World Health Organization. Blue bars
 life expectancy at birth (years), males; green bars  life expectancy at
birth (years), females; pink bars  healthy life expectancy at birth (years),
males; gray bars  healthy life expectancy at birth (years), females.ess to services being dissimilar because of the many differ-
nt organizational structures for health delivery. At the
ame time, substantial variation exists in expenditure on
ealth expressed as a percentage of gross domestic product
GDP) (Fig. 2). The proportion of monies directed into
ealth services from public and private sources also varies
etween countries. Large differences are found in the ex-
enditure expressed per capita (Fig. 3), but in almost all
ountries expenditure on health has increased. These are
rude overall measures of health and expenditure, but a
imple interpretation would suggest that those countries
hat maintain a high mean life expectancy at the lowest
DP are the most efficient. Such an argument hides many
ther decisions to be made within society, particularly
Figure 2 Health Expenditure Expressed
as a Percentage of GDP
Source: World Health Statistics 2006, World Health Organization.
Green bars  privately funded; blue bars  publicly funded.
GDP  gross domestic product.
Figure 3 Per Capita Total Expenditure on Health
at International Dollar Rates, Year 2003
Source: World Health Statistics 2006, World Health Organization.
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n the last years of life.
Cardiovascular disease is now the leading cause of death
nd disability in most advanced countries, although the
reater problem is in developing countries, where the popu-
ation is larger and 80% of deaths due to cardiovascular
isease occur. And yet, in Europe, the public perception is
ifferent, which is a consequence of the 5 great myths of
ardiovascular medicine. Cardiovascular disease represents a
leasant way to die, not a sentiment to be expressed by
he countries of Europe and the world do, to a large extent,
epresent a laboratory in which different health systems have
een tested and in which different approaches have been
aken. . .
hose with heart failure. Cardiovascular disease is disease of
ffluence, denying the role of poverty and societal pressures.
ardiovascular disease is a personal responsibility not to be
aken on by government, thus transferring costs to the indi-
idual. Cardiovascular disease is a disease of the elderly.
ardiovascular disease is a problem of male gender, an idea
igorously countered by initiatives relating to heart disease
n women begun in the U.S. and now evident across the
orld and promoted by the World Heart Federation. Somef these myths are partly the consequence of the public and
oliticians misunderstanding statements from the cardio-
ascular community. Perhaps the greatest of these is to mis-
nderstand the fact that age-adjusted mortality can be de-
lining at the same time as the total prevalence of a disease
s increasing. The enthusiasm to portray success can conceal
he nature of the health threat to the population.
The countries of Europe and the world do, to a large
xtent, represent a laboratory in which different health sys-
ems have been tested and in which different approaches
ave been taken to the delivery of health services and to the
unding of clinical research. There is much to be learned by
tudying the merits or otherwise of these differences. Future
rticles will focus on many topics but will include the
eaching and training of doctors, the regulation of doctors,
he funding of research, the validity and consistency of
uidelines, and what measures are being taken to respond
o the epidemic of cardiovascular in particular parts
f Europe. The intent is that this exchange of views will
nform doctors across the world, initiate discussion, provide
deas for change, and allow doctors and health professionals
o have knowledge of the problems of others and perhaps
ecome aware of possible new solutions.doi:10.1016/j.jacc.2006.10.002
